Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMC 3714845)

Published in Int J Radiat Oncol Biol Phys on April 09, 2012

Authors

Silvia C Formenti1, Howard Hsu, Maria Fenton-Kerimian, Daniel Roses, Amber Guth, Gabor Jozsef, Judith D Goldberg, J Keith Dewyngaert

Author Affiliations

1: Department of Radiation Oncology, New York University School of Medicine and Langone Medical Center, New York, NY 10016, USA. silvia.formenti@nyumc.org

Articles cited by this

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet (2011) 9.20

Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet (2010) 8.14

Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol (2010) 5.44

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med (2004) 4.84

Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol (2008) 2.28

Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol (2006) 1.89

Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys (2010) 1.76

Biologic comparison of partial breast irradiation protocols. Int J Radiat Oncol Biol Phys (2004) 1.71

Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys (2004) 1.51

Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol (2010) 1.48

Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2010) 1.34

Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma. Int J Radiat Oncol Biol Phys (2009) 1.30

Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys (2003) 1.18

Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2009) 1.14

T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients--pilot feasibility study. Radiology (2002) 0.98

A dielectric method for measuring early and late reactions in irradiated human skin. Radiother Oncol (1998) 0.89

Prospective study of cone-beam computed tomography image-guided radiotherapy for prone accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2011) 0.86

Prone accelerated partial breast irradiation after breast-conserving surgery: compliance to the dosimetry requirements of RTOG-0413. Int J Radiat Oncol Biol Phys (2012) 0.82

Radiotherapy for breast cancer in the 21st Century. Breast J (2010) 0.79

Articles by these authors

Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res (2009) 4.58

Prone vs supine positioning for breast cancer radiotherapy. JAMA (2012) 2.32

Survival in familial dysautonomia: Impact of early intervention. J Pediatr (2002) 1.98

Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol (2004) 1.73

Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila) (2010) 1.68

Fludrocortisone in patients with familial dysautonomia--assessing effect on clinical parameters and gene expression. Clin Auton Res (2005) 1.52

The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. Clin Cancer Res (2006) 1.51

Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys (2004) 1.51

Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. Arch Pathol Lab Med (2008) 1.49

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clin Cancer Res (2012) 1.46

Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys (2002) 1.40

Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol (2006) 1.29

Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol (2007) 1.23

Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). J Am Coll Cardiol (2010) 1.20

Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am J Transl Res (2009) 1.17

Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2005) 1.13

Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival. Breast Cancer Res Treat (2010) 1.12

CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort. PLoS One (2012) 1.12

Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. Int J Radiat Oncol Biol Phys (2012) 1.10

Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2012) 1.10

Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma. Clin Cancer Res (2009) 1.01

Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing. Pediatr Res (2009) 1.00

Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys (2012) 1.00

Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. Blood (2013) 0.99

EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions. Clin Cancer Res (2013) 0.99

T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients--pilot feasibility study. Radiology (2002) 0.98

High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Res (2010) 0.97

Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity. Kidney Int (2004) 0.96

Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework. Acad Med (2015) 0.96

Proactive approach to lymphedema risk reduction: a prospective study. Ann Surg Oncol (2014) 0.96

Optimization of MammoSite therapy. Int J Radiat Oncol Biol Phys (2004) 0.95

Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers. BMC Cancer (2010) 0.94

PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition. Mol Cancer Res (2013) 0.94

A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF). Br J Haematol (2013) 0.94

Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique. Int J Radiat Oncol Biol Phys (2011) 0.94

Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma. Anticancer Res (2010) 0.92

The PI3K/Akt/mTOR pathway mediates retinal progenitor cell survival under hypoxic and superoxide stress. Mol Cell Neurosci (2011) 0.92

Comparison of three-dimensional versus intensity-modulated radiotherapy techniques to treat breast and axillary level III and supraclavicular nodes in a prone versus supine position. Radiother Oncol (2011) 0.92

Fetal radiation doses for model C gamma knife radiosurgery. Neurosurgery (2003) 0.91

Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2013) 0.90

Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer. Breast Cancer Res (2014) 0.90

Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Hum Genet (2013) 0.90

Dosimetric comparison of CyberKnife with other radiosurgical modalities for an ellipsoidal target. Neurosurgery (2003) 0.88

Coverage of axillary lymph nodes in supine vs. prone breast radiotherapy. Int J Radiat Oncol Biol Phys (2008) 0.88

Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer. Am J Respir Cell Mol Biol (2002) 0.88

Interstitial fluid pressure correlates with intravoxel incoherent motion imaging metrics in a mouse mammary carcinoma model. NMR Biomed (2011) 0.86

Radiotherapy and stereotactic radiosurgery for pituitary tumors. Neurosurg Clin N Am (2003) 0.85

Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence. Eur Urol (2011) 0.84

Elastic fiber pattern in regressing melanoma: a histochemical and immunohistochemical study. J Cutan Pathol (2010) 0.84

S-adenosylmethionine as a biomarker for the early detection of lung cancer. Chest (2007) 0.84

Importance of MR technique for stereotactic radiosurgery. Neuro Oncol (2003) 0.84

Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms. Exp Hematol (2009) 0.84

The role of a prone setup in breast radiation therapy. Front Oncol (2011) 0.83

IKBKAP mRNA in peripheral blood leukocytes: a molecular marker of gene expression and splicing in familial dysautonomia. Pediatr Res (2008) 0.83

Measurements of the relative output factors for CyberKnife collimators. Neurosurgery (2004) 0.83

Risk of malignancy in follicular neoplasms without nuclear atypia: statistical analysis of 397 thyroidectomies. Endocr Pract (2004) 0.83

Accelerated intensity-modulated radiotherapy to breast in prone position: dosimetric results. Int J Radiat Oncol Biol Phys (2007) 0.83

Outcomes of coronary artery bypass grafting and reduction annuloplasty for functional ischemic mitral regurgitation: a prospective multicenter study (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). J Thorac Cardiovasc Surg (2011) 0.82

Gene profiling of normal human bronchial epithelial cells in response to asbestos and benzo(a)pyrene diol epoxide (BPDE). J Environ Pathol Toxicol Oncol (2007) 0.82

A pilot study of letrozole for one year in women at enhanced risk of developing breast cancer: effects on mammographic density. Anticancer Res (2012) 0.82

Prone accelerated partial breast irradiation after breast-conserving surgery: compliance to the dosimetry requirements of RTOG-0413. Int J Radiat Oncol Biol Phys (2012) 0.82

Comparison of Acute and Late Toxicity of Two Regimens of 3- and 5-Week Concomitant Boost Prone IMRT to Standard 6-Week Breast Radiotherapy. Front Oncol (2012) 0.82

A panoramic view of the skull base: systematic review of open and endoscopic endonasal approaches to four tumors. Pituitary (2014) 0.81

Meta-analysis to assess the appropriate endpoint for slow pathway ablation of atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol (2010) 0.81

Tubular Carcinoma of the Breast: Immunohistochemical and DNA Flow Cytometric Profile. Breast J (1999) 0.81

Screening prior to Breast Cancer Diagnosis: The More Things Change, the More They Stay the Same. Int J Breast Cancer (2013) 0.80

Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy. Int J Radiat Oncol Biol Phys (2012) 0.79

Studying physician knowledge, attitudes, and practices regarding the herpes zoster vaccine to address perceived barriers to vaccination. Cornea (2013) 0.79

A Web- and Mobile-Based Intervention for Women Treated for Breast Cancer to Manage Chronic Pain and Symptoms Related to Lymphedema: Randomized Clinical Trial Rationale and Protocol. JMIR Res Protoc (2016) 0.79

Designing and implementing INTREPID, an intensive program in translational research methodologies for new investigators. Clin Transl Sci (2014) 0.78

Is there a role for an external beam boost in cervical cancer radiotherapy? Front Oncol (2013) 0.78

Impact of socioeconomic status and sociodemographic factors on melanoma presentation among ethnic minorities. J Community Health (2011) 0.78

Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI. Integr Biol (Camb) (2011) 0.78

Hypofractionated radiation therapy for early stage breast cancer: outcomes, toxicities, and cost analysis. Breast J (2014) 0.78

Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomark (2012) 0.78

Automated beam placement for breast radiotherapy using a support vector machine based algorithm. Med Phys (2012) 0.78

Breast radiotherapy in the prone position primarily reduces the maximum out-of-field measured dose to the ipsilateral lung. Med Phys (2012) 0.78

Evaluation of pro-carboxypeptidase A and carboxypeptidase A as serologic markers for adenocarcinoma of the pancreas. HPB (Oxford) (2006) 0.78

Feasibility of accelerated whole-breast radiation in the treatment of patients with ductal carcinoma in situ of the breast. Clin Breast Cancer (2008) 0.77

Exploring the utility of automated drug alerts in home healthcare. J Healthc Qual (2006) 0.77

MammoSite radiation therapy system. Breast (2003) 0.76

Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma. Anticancer Res (2011) 0.76

A note on monotonicity assumptions for exact unconditional tests in binary matched-pairs designs. Biometrics (2011) 0.75

Systematic missing-at-random (SMAR) design and analysis for translational research studies. Int J Biostat (2008) 0.75

Agent of opportunity risk mitigation: people, engineering, and security efficacy. Disaster Med Public Health Prep (2010) 0.75

Improving adherence to national recommendations for zoster vaccination through simple interventions. Eye Contact Lens (2014) 0.75

Receptor status and ethnicity of indigent patients with breast cancer in New York City. Arch Surg (2008) 0.75

Dose to craniofacial region through portal imaging of pediatric brain tumors. J Appl Clin Med Phys (2012) 0.75